Shedding of the soluble IL-6R is triggered during apoptosis

被引：0
|
作者：
不详
机构：
来源：
IMMUNOBIOLOGY | 2005年 / 210卷 / 6-8期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：523 / 523
页数：1
相关论文
共 50 条
  • [21] Regulation of thrombosis during Behcet disease through EBI3, IL-6 and IL-6R
    Ghozali, Nourelhouda
    Belguendouz, Houda
    Abdesselam, Zahira
    Messaoudene, Djamel
    Hadjimi, Zohra
    Terahi, Malika
    Kediha, Islam
    Lahmar, Kariam
    Pacha, Lamia Ali
    Belkacem, Habiba Amroun Ait
    Boukoffa, Chafia Touil
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 240 - 240
  • [22] Proteolytic Origin of the Soluble Human IL-6R In Vivo and a Decisive Role of N-Glycosylation
    Riethmueller, Steffen
    Somasundaram, Prasath
    Ehlers, Johanna C.
    Hung, Chien-Wen
    Flynn, Charlotte M.
    Lokau, Juliane
    Agthe, Maria
    Duesterhoeft, Stefan
    Zhu, Yijue
    Groetzinger, Joachim
    Lorenzen, Inken
    Koudelka, Tomas
    Yamamoto, Kosuke
    Pickhinke, Ute
    Wichert, Rielana
    Becker-Pauly, Christoph
    Raedisch, Marisa
    Albrecht, Alexander
    Hessefort, Markus
    Stahnke, Dominik
    Unverzagt, Carlo
    Rose-John, Stefan
    Tholey, Andreas
    Garbers, Christoph
    PLOS BIOLOGY, 2017, 15 (01):
  • [23] Human but not mouse IL-6R is a substrate for TACE: Analysis of the molecular basis of species specificity using chimeric IL-6R proteins
    Garbers, Christoph
    Chalaris, Athena
    Meyer, Dorte
    Jaenner, Nathalie
    Rose-John, Stefan
    Scheller, Juergen
    CYTOKINE, 2010, 52 (1-2) : 37 - 37
  • [24] Blockade of IL-6 signaling via soluble IL-6R is superior to global IL-6 blockade by antibodies in models of inflammation and septic shock
    Rose-John, Stefan
    Barkhausen, Tanja
    Adam, Nina
    Chalaris, Athena
    Waetzig, Georg
    Scheller, Juergen
    CYTOKINE, 2010, 52 (1-2) : 100 - 101
  • [25] PROTEOLYTIC ORIGIN OF THE SOLUBLE HUMAN IL-6R IN VIVO AND A DECISIVE ROLE OF N-GLYCOSYLATION
    Garbers, C.
    Riethmueller, S.
    Somasundaram, P.
    Ehlers, J. C.
    Koudelka, T.
    Hung, C. -W.
    Tholey, A.
    Rose-John, S.
    CYTOKINE, 2016, 87 : 60 - 60
  • [26] Myocardial IL-6R expression and IL-6 signaling following exercise
    McGinnis, Graham Ripley
    Barberio, Matthew
    Ballmann, Christopher
    Peters, Bridget
    Quindry, John
    Amin, Rajesh
    FASEB JOURNAL, 2013, 27
  • [27] CLAZAKIZUMAB (CLZ, ANTI-IL-6) AND TOCILIZUMAB (TCZ, ANTI-IL-6 RECEPTOR) DIFFERENTIALLY AFFECT IL-6/IL-6R SIGNALING BY MODULATING SOLUBLE IL-6R & GP130 IN PATIENTS TREATED FOR CHRONIC ANTIBODY-MEDIATED REJECTION (CABMR)
    Shin, Bongha
    Vo, Ashley
    Ge, Shili
    Petrosyan, Anna
    Ammerman, Noriko
    Jordan, Stanley
    Toyoda, Mieko
    TRANSPLANT INTERNATIONAL, 2019, 32 : 410 - 410
  • [28] Soluble interleukin-6 receptor (sIL-6R) makes IL-6R negative T cell line respond to IL-6;: it inhibits TNF production
    Igaz, P
    Horváth, A
    Horváth, B
    Szalai, C
    Pállinger, É
    Rajnavölgyi, É
    Tóth, S
    Rose-John, S
    Falus, A
    IMMUNOLOGY LETTERS, 2000, 71 (03) : 143 - 148
  • [29] The IL-6/IL-6R binding interface. Proposed mechanism of interaction
    Kalai, M
    MonteroJulian, FA
    Grotzinger, J
    Fontaine, V
    Vandenbussche, P
    Deschuyteneer, R
    Wollmer, A
    Brailly, H
    Content, J
    ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, 1996, 104 (03) : B43 - B43
  • [30] Discovery and characterization of a monoclonal antibody taroeting a conformational epitope of IL-6/IL-6Rα to inhibit IL-6/IL-6Rα/gp130 hexameric signaling complex formation
    Chou, Chun-Chi
    Hua, Kuo-Tai
    Chen, Min-Wei
    Wu, Chin-Jui
    Hsu, Chun-Hua
    Wang, Jann-Tay
    Hsiao, Michael
    Wei, Lin-Hung
    MABS, 2022, 14 (01)
12345